Use of AI in the Medicinal Product Lifecycle: A Case Study

In this session we will discuss the legal and compliance implications of a pharmaceutical company’s use of AI across the medicinal product lifecycle, including:

• The implications of the EU AI Act
• Use of AI in clinical trials
• GxP considerations
• Preparation of promotional materials using AI
• AI interactions with HCPs and sales reps
• AI-specific data protection issues
• Red-flag IP considerations

This webinar is aimed at in-house legal counsel.